Literature DB >> 25788698

Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS.

Simona Rossi1, Alessia Serrano2, Valeria Gerbino3, Alessandra Giorgi4, Laura Di Francesco4, Monica Nencini5, Francesca Bozzo3, Maria Eugenia Schininà4, Claudia Bagni6, Gianluca Cestra7, Maria Teresa Carrì3, Tilmann Achsel8, Mauro Cozzolino9.   

Abstract

A common feature of non-coding repeat expansion disorders is the accumulation of RNA repeats as RNA foci in the nucleus and/or cytoplasm of affected cells. These RNA foci can be toxic because they sequester RNA-binding proteins, thus affecting various steps of post-transcriptional gene regulation. However, the precise step that is affected by C9orf72 GGGGCC (G4C2) repeat expansion, the major genetic cause of amyotrophic lateral sclerosis (ALS), is still poorly defined. In this work, we set out to characterise these mechanisms by identifying proteins that bind to C9orf72 RNA. Sequestration of some of these factors into RNA foci was observed when a (G4C2)31 repeat was expressed in NSC34 and HeLa cells. Most notably, (G4C2)31 repeats widely affected the distribution of Pur-alpha and its binding partner fragile X mental retardation protein 1 (FMRP, also known as FMR1), which accumulate in intra-cytosolic granules that are positive for stress granules markers. Accordingly, translational repression is induced. Interestingly, this effect is associated with a marked accumulation of poly(A) mRNAs in cell nuclei. Thus, defective trafficking of mRNA, as a consequence of impaired nuclear mRNA export, might affect translation efficiency and contribute to the pathogenesis of C9orf72 ALS.
© 2015. Published by The Company of Biologists Ltd.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; C9orf72; Stress granules; mRNA

Mesh:

Substances:

Year:  2015        PMID: 25788698     DOI: 10.1242/jcs.165332

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  64 in total

Review 1.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 2.  Disease Mechanisms of C9ORF72 Repeat Expansions.

Authors:  Tania F Gendron; Leonard Petrucelli
Journal:  Cold Spring Harb Perspect Med       Date:  2018-04-02       Impact factor: 6.915

Review 3.  RNA-mediated toxicity in C9orf72 ALS and FTD.

Authors:  Zachary T McEachin; Janani Parameswaran; Nisha Raj; Gary J Bassell; Jie Jiang
Journal:  Neurobiol Dis       Date:  2020-08-21       Impact factor: 5.996

Review 4.  PURA, the gene encoding Pur-alpha, member of an ancient nucleic acid-binding protein family with mammalian neurological functions.

Authors:  Dianne C Daniel; Edward M Johnson
Journal:  Gene       Date:  2017-12-06       Impact factor: 3.688

Review 5.  mRNP assembly, axonal transport, and local translation in neurodegenerative diseases.

Authors:  Bilal Khalil; Dmytro Morderer; Phillip L Price; Feilin Liu; Wilfried Rossoll
Journal:  Brain Res       Date:  2018-02-17       Impact factor: 3.252

6.  A synthetic Pur-based peptide binds and alters G-quadruplex secondary structure present in the expanded RNA repeat of C9orf72 ALS/FTD.

Authors:  Margaret J Wortman; Ayuna V Dagdanova; Andrea M Clark; Earl W Godfrey; Steven M Pascal; Edward M Johnson; Dianne C Daniel
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2020-02-06       Impact factor: 4.739

Review 7.  Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.

Authors:  Xinmei Wen; Thomas Westergard; Piera Pasinelli; Davide Trotti
Journal:  Neurosci Lett       Date:  2016-09-13       Impact factor: 3.046

8.  Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation.

Authors:  Kohsuke Kanekura; Takuya Yagi; Alexander J Cammack; Jana Mahadevan; Masahiko Kuroda; Matthew B Harms; Timothy M Miller; Fumihiko Urano
Journal:  Hum Mol Genet       Date:  2016-02-29       Impact factor: 6.150

9.  Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.

Authors:  Jie Jiang; Qiang Zhu; Tania F Gendron; Shahram Saberi; Melissa McAlonis-Downes; Amanda Seelman; Jennifer E Stauffer; Paymaan Jafar-Nejad; Kevin Drenner; Derek Schulte; Seung Chun; Shuying Sun; Shuo-Chien Ling; Brian Myers; Jeffery Engelhardt; Melanie Katz; Michael Baughn; Oleksandr Platoshyn; Martin Marsala; Andy Watt; Charles J Heyser; M Colin Ard; Louis De Muynck; Lillian M Daughrity; Deborah A Swing; Lino Tessarollo; Chris J Jung; Arnaud Delpoux; Daniel T Utzschneider; Stephen M Hedrick; Pieter J de Jong; Dieter Edbauer; Philip Van Damme; Leonard Petrucelli; Christopher E Shaw; C Frank Bennett; Sandrine Da Cruz; John Ravits; Frank Rigo; Don W Cleveland; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2016-04-21       Impact factor: 17.173

Review 10.  ALS: Recent Developments from Genetics Studies.

Authors:  Martine Therrien; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.